ClinicalTrials.gg
TerminatedNCT03806023Updated Oct 5, 2020

EMG Triggered Closed-Loop Stimulation for Spinal Cord Injury Individuals

An interventional study of hand movements (signals from thumb muscle) triggered PNS and TMS in Spinal Cord Injuries, sponsored by Bronx VA Medical Center. Terminated at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-10-05.

Sponsored by Bronx VA Medical Center · Not applicable, Interventional, and Basic science

How we know

Why this study was terminated
Funding expired due to grant for new project (NCT03851302)

From the registry’s dates

  • Primary completion was Feb 2020, 6 years 8 months ago, and no results have been posted to the registry.
  • Registered 11 months after the study started (first participant enrolled Feb 2018, registered Jan 2019).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 968 studies in Spinal Cord Injuries with a site in United States — 249 open to participants now, 308 under way, 7 of them phase 3. Spinal Cord Injuries · United States.

Enrollment
699th of 836
8 · median 24
Started
2018
with 65 others
No phase
601 of 968
189 open now
Registered
494th of 968
by date

Among the 968 studies in Spinal Cord Injuries with a site in United States, this one is the 699th largest by enrollment of the 836 interventional ones that give a count, is one of 66 that started in 2018, is one of 601 with no phase, and was the 494th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

249 of the 968 studies in Spinal Cord Injuries with a site in United States are open now. Recruiting first, the newest first:

244 more — sign in →

All 249 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 968 studies in Spinal Cord Injuries with a site in United States, or all of them as a file.
02

Study summary

Most individuals with spinal cord injury (SCI) have residual nerve circuits. The investigators aim to strengthen those circuits to improve motor recovery after injury. To do this, the investigators are attempting to pair electrical and magnetic stimulation with physical training targeted toward the connections between nerve circuits. Past studies by other groups have shown that synapse strength can be improved temporarily after a short period of paired stimulation between the brain (motor cortex) and the peripheral nerves serving target muscles - in other words, "Fire Together, Wire Together".

The brain's intention to move a muscle can be read by recording surface electrical activity over target muscles (electromyography or EMG). In animal models of SCI, scientists have successfully used target muscle EMG to trigger spinal cord electrical stimulation pulses while the animals perform physical exercises. Using the body's own signals to trigger nerve stimulation is called "closed-loop stimulation". This might be an optimal method to coordinate brain and nerve activity, especially with the clinical advantage of being possible to combine with physical exercise training. However, whether EMG-triggered closed loop stimulation has the same amount of effect when applied non-invasively in humans is still unknown.

This proposed study is a proof-of-principle to demonstrate the potential of non-invasive closed-loop stimulation in humans with incomplete cervical SCI. We will test different combinations of triggered and non-triggered electrical and magnetic stimulation, and record the short-term effects on nerve transmission and skilled function of hand muscles. This pilot study will be a foundation for future studies combining EMG-triggered stimulation with long-term physical exercise training.

Read the detailed description

In both animal models and humans with spinal cord injury (SCI), synaptic efficacy between corticospinal axons and spinal motor neurons has improved temporarily after a short period of paired stimulation between motor cortex and spinal or peripheral sites. In a demonstration of closed-loop stimulation in SCI rats, target muscle electromyography (EMG) signals were used to trigger spinal cord electrical stimulation while performing physical retraining. Results showed that EMG-triggered stimulation plus physical retraining led to greater motor recovery than non-triggered stimulation or physical training alone. However, these studies used invasive direct spinal cord stimulation in rodent models. Whether this approach can work non-invasively in humans remains unknown.

Twenty participants (10 able bodied and 10 SCI subjects) will be recruited. Each subject will undergo five different 20-minute interventions. Stimulation will be delivered at the motor cortex via transcranial magnetic stimulation (TMS), the median nerve, or both. Stimulation will occur either while the subject is passively at rest or triggered by reaching endogenous EMG threshold during a pinch task. Outcomes will be measured at baseline and every 20 minutes for one hour after the intervention.

The investigators hypothesize that for at least 20 minutes after stimulation, one session of EMG-triggered stimulation will significantly improve motor evoked potential amplitude, increase cortical silent period duration, and decrease time required to complete a pegboard task compared with one session of passively delivered stimulation. The investigators further hypothesize that EMG triggered median nerve stimulation alone will provide equal or greater benefits as EMG triggered TMS or EMG-triggered paired stimulation.

Hypothesis 1: One session of EMG-triggered stimulation will significantly improve motor evoked potential (MEP) amplitude, increase cortical silent period duration of APB, and decrease time required to complete a manual pegboard task compared with one session of passively delivered stimulation or one session of voluntary contraction alone for at least 20 minutes post-stimulation.

Hypothesis 2: EMG-triggered PNS alone will result in equal or greater effects than EMG triggered TMS or TMS+PNS paired stimulation. This would indicate that EMG triggered PNS might be used as a potential intervention to add during physical training, a setting in which TMS is difficult to apply.

03

Conditions studied

  • Spinal Cord Injuries

Keywords

  • transcutaneous electric nerve stimulation
  • transcranial magnetic stimulation
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 75 years;
  • Chronic (more than 12 months since injury) motor-incomplete SCI between neurological levels C2-C8
  • Score of 3 or more (out of 5) on manual muscle testing of finger extension, finger flexion, or finger abduction in left or right hand;
  • Detectable F-wave responses of the left or right abductor pollicis brevis (APB) to median nerve stimulation;
  • Detectable motor evoked potentials in left or right APB;
  • Able to perform thumb-middle finger opposition pinch task with detectable APB EMG muscle activity.

Exclusion criteria

Exclusion Criteria:

  • Multiple spinal cord lesions;
  • History of seizures;
  • Ventilator dependence or patent tracheostomy site;
  • Use of medications that significantly lower seizure threshold, such as tricyclic antidepressants, amphetamines, neuroleptics, dalfampridine, and bupropion;
  • History of stroke, brain tumor, brain abscess, or multiple sclerosis;
  • History of moderate or severe head trauma (loss of consciousness for greater than one hour or evidence of brain contusion or hemorrhage or depressed skull fracture on prior imaging);
  • History of implanted brain/spine/nerve stimulators, aneurysm clips, ferromagnetic metallic implants, or cardiac pacemaker/defibrillator;
  • Significant coronary artery or cardiac conduction disease;
  • Recent history (within past 6 months) of recurrent autonomic dysreflexia, defined as a syndrome of sudden rise in systolic pressure greater than 20 mm Hg or diastolic pressure greater than 10 mm Hg, without rise in heart rate, accompanied by symptoms such as headache, facial flushing, sweating, nasal congestion, and blurry vision (this will be closely monitored during all screening and testing procedures);
  • History of bipolar disorder;
  • History of suicide attempt;
  • Active psychosis;
  • Heavy alcohol consumption (greater than equivalent of 5 oz of liquor) within previous 48 hours;
  • Open skin lesions over the face, neck, shoulders, or arms;
  • Pregnancy
  • Unsuitable for study participation as determined by study physician.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    All subjects

    All subjects undergo same full protocol, including PNS and TMS at rest and active hand movements (signals from thumb muscle) triggered PNS and TMS.

    Device: hand movements (signals from thumb muscle) triggered PNS and TMS

Interventions

  • Devicehand movements (signals from thumb muscle) triggered PNS and TMS

    PNS, TMS or PNS+TMS will be delivered while the participant performs specific finger tasks at different degrees of effort. This is an experiment designed to detect momentary changes in muscle function.

06

What researchers measure

Primary outcomes

  1. Change in motor evoked potential (MEP) amplitude of the abductor pollicis brevis (APB) muscle response to single pulses of TMS

    Time frame: Assessed pre, then 0, 20, 40, and 60 minutes post-intervention.

  2. Hand dexterity

    Timed performance on a grooved pegboard task.

    Time frame: Assessed pre, then 0, 20, 40, and 60 minutes post-intervention.

Secondary outcomes

  1. Grip strength

    Strength will be quantified using hand-held wireless dynamometry.

    Time frame: Assessed pre, then 0, 20, 40, and 60 minutes post-intervention.

  2. Change in the duration of the 'cortical silent period' after TMS stimulation during APB contraction

    Time frame: Assessed pre, then 0, 20, 40, and 60 minutes post-intervention.

  3. F-wave responses of the APB muscle

    Time frame: Assessed pre, then 0, 20, 40, and 60 minutes post-intervention.

07

Study locations

1 site
  • James J. Peters VA Medical Center
    Bronx, New York 10468, United States
08

References and documents

Individual participant data

Plan to share: Yes — A Limited Dataset (LDS) will be shared in electronic format pursuant to a VA-approved Data Use Agreement. Individually Identifiable Data will be shared pursuant to valid HIPAA Authorization, Informed Consent, and an appropriate written agreement limiting use of the data to the conditions as described in the authorization and consent, and a written assurance from the recipient that the information will be maintained in accordance with the security requirements of 38 CFR Part 1.466.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2018 to primary completion in Feb 2020, 24 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 14, 2019
First posted
Jan 16, 2019
StartActual
Feb 1, 2018
Primary completionActual
Feb 28, 2020
CompletionActual
Feb 28, 2020
Last update
Oct 5, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 5, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03806023
Lead sponsor
Bronx VA Medical Center
Responsible party
Noam Y. Harel (Principal Investigator, Bronx VA Medical Center) — Principal investigator
First posted
Jan 16, 2019
Start date
Feb 1, 2018
Primary completion
Feb 28, 2020
Completion
Feb 28, 2020
Last update
Oct 5, 2020

Study contacts

Noam Y Harel, MD, PhD
principal investigator · James J. Peters VA Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion